• Skip to main content
  • Skip to after header navigation
  • Skip to site footer
ERN: Emerging Researchers National Conference in STEM

ERN: Emerging Researchers National Conference in STEM

  • About
    • About AAAS
    • About NSF
    • About the Conference
    • Project Team
    • Advisory Board
  • Conference
  • Abstracts
    • Abstract Submission Process
    • Abstract Submission Guidelines
    • Presentation Guidelines
  • Travel Awards
  • Resources
    • Award Winners
    • Code of Conduct-AAAS Meetings
    • Code of Conduct-ERN Conference
    • Conference Agenda
    • Conference Materials
    • Conference Program Books
    • ERN Photo Galleries
    • Events | Opportunities
    • Exhibitor Info
    • HBCU-UP PI/PD Meeting
    • In the News
    • NSF Harassment Policy
    • Plenary Session Videos
    • Professional Development
    • Science Careers Handbook
    • Additional Resources
    • Archives
  • Engage
    • Webinars
    • ERN 10-Year Anniversary Videos
    • Plenary Session Videos
  • Contact Us
  • Login

TEPB-CS and TEAB-CS: Gene Therapy Alternatives

Graduate #58
Discipline: Nanoscience
Subcategory: Cancer Research
Session: 1
Room: McKinley

Deborah Ehie - Missouri State University
Co-Author(s): Dr. Kyoungtae Kim, Department of Biology, Missouri State University; Dr. Reza Sedaghat-Herati, Department of Chemistry, Missouri State University.



Antiviral vectors have been a principal delivery agent (among other agents such as metal nanoparticles) for current gene therapy techniques used for chemotherapy. Some of these kinds of gene delivery agent can be toxic to the cells due to the unpredictability and cytotoxicity of these vectors. Although these vectors can be useful, they can also be harmful to human cells. Many studies have shown the effectiveness of Chitin and Chitosan on drug delivery to these cancer cells. The problem at hand lies in the solubility of Chitin and Chitosan in the cells. A long term-goal of my study involves the use of two derivatives of Chitosan, triethylphosphonium butamide-chitosan (TEPB-CS or TEPB) and triethylammonium butamide-chitosan (TEAB-CS or TEAB) for gene therapy and drug delivery on cancer cells. This study presents the efficacy of these chemicals on cell proliferation of, cytotoxicity of, and gene transfection into HeLa cells. It was found that the chitosan derivatives display negligible effects on cell proliferation with their concentrations, ranging from 0 to 200 ug/mL, which further emphasizes their non-toxicity on cells. Additionally, the measurement of reactive oxygen species (ROS) with Dihydrorhodamine123 (DHR123) resulted in reduced oxidative stress in cell groups treated with these chemicals. This was followed by transfection of a GFP-fused plasmid into the HeLa cells in order to determine the efficiency of TEAB and TEPB as agents for gene therapy. Overall, these chitosan derivatives are considered safe agents for gene delivery experiments as will be discussed in my presentation.

Funder Acknowledgement(s): Missouri State University, Dr. Tayo Obafemi-Ajayi (via the LSAMP program), Dr. Kyoungtae Kim, Dr. Reza Sedaghat-Herati

Faculty Advisor: Dr. Kyoungtae Kim, kkim@missouristate.edu

Role: I worked on the experimental process of the research

Sidebar

Abstract Locators

  • Undergraduate Abstract Locator
  • Graduate Abstract Locator

This material is based upon work supported by the National Science Foundation (NSF) under Grant No. DUE-1930047. Any opinions, findings, interpretations, conclusions or recommendations expressed in this material are those of its authors and do not represent the views of the AAAS Board of Directors, the Council of AAAS, AAAS’ membership or the National Science Foundation.

AAAS

1200 New York Ave, NW
Washington,DC 20005
202-326-6400
Contact Us
About Us

  • LinkedIn
  • Facebook
  • Instagram
  • Twitter
  • YouTube

The World’s Largest General Scientific Society

Useful Links

  • Membership
  • Careers at AAAS
  • Privacy Policy
  • Terms of Use

Focus Areas

  • Science Education
  • Science Diplomacy
  • Public Engagement
  • Careers in STEM

Focus Areas

  • Shaping Science Policy
  • Advocacy for Evidence
  • R&D Budget Analysis
  • Human Rights, Ethics & Law

© 2023 American Association for the Advancement of Science